Coffee consumption and risk of chronic diseases: Changing our views

American Journal of Clinical Nutrition

Volumn 95, Issue 4, 2012, Pages 787-788

  Lopez Garcia, Esther ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ADRENALIN; CAFFEINE; CHOLESTEROL; DITERPENE; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHENOL;

ADIPOCYTE; ANTIOXIDANT ACTIVITY; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; CHRONIC DISEASE; COFFEE; COFFEE INTAKE; CORONARY ARTERY DISEASE; DIETARY INTAKE; DISEASE ASSOCIATION; EDITORIAL; FOLLOW UP; HUMAN; INSULIN SENSITIVITY; LIVER FUNCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK; SOCIAL INTERACTION; STROKE; SYSTEMATIC REVIEW (TOPIC);

CARDIOVASCULAR DISEASES; COFFEE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; NEOPLASMS;

EID: 84859059736     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.111.033761     Document Type: Editorial

References (11)

1. Hartley TR, Lovallo WR, Whitsett TL. Cardiovascular effects of caffeine in men and women. Am J Cardiol 2004;93:1022-6. (Pubitemid 38479458)
2. Baylin A, Hernandez-Diaz S, Kabagambe EK, Siles X, Campos H. Transient exposure to coffee as a trigger of a first nonfatal myocardial infarction. Epidemiology 2006;17:506-11. (Pubitemid 44223057)
3. van Dam RM, Feskens EJ. Coffee consumption and risk of type 2 diabetes mellitus. Lancet 2002;360:1477-8. (Pubitemid 35356327)
4. van Dam RM. Coffee and type 2diabetes: from beans to beta-cells. Nutr Metab Cardiovasc Dis 2006;16:69-77.
5. Gómez-Ruiz JA, Leake DS, Ames JM. In vitro antioxidant activity of coffee compounds and their metabolites. J Agric Food Chem 2007; 55:6962-9. (Pubitemid 47338933)
6. Huber WW, Scharf G, Nagel G, Prustomersky S, Schulte-Hermann R, Kaina B. Coffee and its chemopreventive components kahweol and cafestol increase the activity of O6-methylguanine-DNA methyltransferase in rat liver-comparison with phase II xenobiotic metabolism. Mutat Res 2003;522:57-68. (Pubitemid 36216301)
7. Floegel A, Pischon T, Bergmann MM, Teucher B, Kaaks R, Boeing H. Coffee consumption and risk of chronic disease in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Germany study. Am J Clin Nutr 2012;95:901-8.
8. Jee SH, He J, Appel LJ, Whelton PK, Suh I, Klag MJ. Coffee consumption and serum lipids: a meta-analysis of randomized controlled clinical trials. Am J Epidemiol 2001;153:353-62. (Pubitemid 32144561)
9. Noordzij M, Uiterwaal CS, Arends LR, Kok FJ, Grobbee DE, Geleijnse JM. Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of randomized controlled trials. J Hypertens 2005; 23:921-8. (Pubitemid 40637906)
10. Wedick NM, Brennan AM, Sun Q, Hu FB, Mantzoros CS, van Dam RM. Effects of caffeinated and decaffeinated coffee on biological risk factors for type 2 diabetes: a randomized controlled trial. Nutr J 2011;10:93.
11. Lopez-Garcia E, van Dam RM, Li TY, Rodriguez-Artalejo F, Hu FB. The relationship of coffee consumption with mortality. Ann Intern Med 2008;148:904-14.